{"id":17404,"date":"2020-12-29T07:29:08","date_gmt":"2020-12-29T12:29:08","guid":{"rendered":"https:\/\/medicarereport.org\/?p=17404"},"modified":"2020-12-29T07:29:08","modified_gmt":"2020-12-29T12:29:08","slug":"fda-issues-new-opioid-prescribing-guidelines","status":"publish","type":"post","link":"https:\/\/medicarereport.org\/?p=17404","title":{"rendered":"FDA issues new opioid prescribing guidelines"},"content":{"rendered":"<p>(By\u00a0Maia Anderson for <em>Becker&#8217;s Hospital Review<\/em>)<\/p>\n<p>The FDA has issued new rules related to the prescribing of opioid painkillers.<\/p>\n<p>The rules apply to transmucosal immediate-release fentanyl, or TIRF, drugs. The drugs contain fentanyl, a powerful opioid, and are used to manage breakthrough pain in adults with cancer. To be prescribed a TIRF drug, patients have to be opioid tolerant.\u00a0 Continue reading article <a href=\"https:\/\/www.beckershospitalreview.com\/opioids\/fda-issues-new-opioid-prescribing-guidelines.html\">here&#8230;<\/a><\/p>\n<p><a href=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2017\/08\/FDA-logo.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-7881\" src=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2017\/08\/FDA-logo-300x97.jpg\" alt=\"\" width=\"300\" height=\"97\" srcset=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2017\/08\/FDA-logo-300x97.jpg 300w, https:\/\/medicarereport.org\/wp-content\/uploads\/2017\/08\/FDA-logo.jpg 322w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/a><\/p>\n<pre><strong>Notice:<\/strong> The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link\u2019s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org<\/pre>\n","protected":false},"excerpt":{"rendered":"<p>(By\u00a0Maia Anderson for Becker&#8217;s Hospital Review) The FDA has issued new rules related to the prescribing of opioid painkillers. The<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[31,15],"tags":[],"class_list":["post-17404","post","type-post","status-publish","format-standard","hentry","category-fda","category-part-dprescription-drugs"],"_links":{"self":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/17404","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=17404"}],"version-history":[{"count":1,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/17404\/revisions"}],"predecessor-version":[{"id":17405,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/17404\/revisions\/17405"}],"wp:attachment":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=17404"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=17404"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=17404"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}